Regulation of antibody immunotherapy by fine-tuning FcR interactions

Video   Apr 22, 2013

 

About the Speaker


Mark Cragg is a Professor in Experimental Cancer Biology at the Cancer Sciences Division of Southampton University School of Medicine, UK. He obtained his PhD in 1998 and did his postdoctoral studies with Martin Glennie in Southampton and then Andreas Strasser at the Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. He has published over 60 papers, many in high impact journals such as the Journal of Clinical Investigation, PNAS, Plos Medicine and Blood and leads a dynamic research group interested in all aspects of how therapeutics such as antibodies result in tumour regression and how they can be improved.
Abstract

Monoclonal antibodies (mAb) represent a growing class of ‘block-buster’ cancer drugs and so understanding of their modes of action is critical. Here, we present evidence that different mAb interact with Fc receptors differently in order to achieve their therapeutic activities.

 
 
 
 

Recommended Videos

PrecisionAb™ Antibodies- Enhance Your Western Blotting Toolbox

Video

These are premium-quality antibodies extensively validated for western blotting.

WATCH NOW

Thermo Scientific™ NanoDrop™ One Microvolume UV-Vis spectrophotometer

Video

Quantify and qualify DNA, RNA, and protein samples with only 1-2 µL and have full-spectral data in seconds using the Thermo Scientific™ NanoDrop™ One Microvolume UV-Vis spectrophotometer.

WATCH NOW

MicroCal PEAQ-ITC: The gold standard for measuring binding affinities

Video

This video describes the 4 main reasons why MicroCal PEAQ-ITC is the ideal instrument for measuring binding affinities.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE